Grayson Norquist
Datos Biográficos
| ID | 5420041 |
|---|---|
| NOMBRE | Grayson Norquist |
| NOMBRES | Grayson |
| APELLIDO | Norquist |
| FIRMA | NORQUIST G |
| AFILIACIONES | Emory University |
| ORCID | 0000-0002-0195-1372 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 6 |
| TOTAL DE CITAS | 2 |
| TOTAL COMO AUTOR | 6 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 1997 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 1 |
Feasibility of an Open Dialogue-Inspired Approach for Young Adults with Psychosis in a Public Hospital System
A Window of Opportunity
The advisory meeting suggested that local policy makers, academics, and community members, together with federal agents, are working to implement behavioral health policy innovation
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established. The authors' primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder.…
Spillover Effects of Benefit Expansions and Carve-Outs on Psychotropic Medication Use and Costs
This paper extends the previous literature examining the impacts of managed behavioral health care carve-outs and mental health parity mandates on mental health and substance abuse (MH/SA) specialty treatment use and costs by considering the effects on psychotropic prescription medication costs. We use multivariate panel data methods to remove underlying secular growth trends, driven by increased demand for improved MH/SA treatment related to pha…
National Institute of Mental Health
Acting Director; Division of Services and Intervention Research; National Institute of Mental Health; Rockville, Maryland (Norquist) Chief; Services Research and Clinical; Epidemiology Branch; National Institute of Mental Health (Magruder)
Mental Health, Disabilities, and Women
Ongoing development and reform of health care systems worldwide are directing the attention of policymakers to the significance of mental disorders and ensuing disabilities. While this awareness has encouraged empirical work and scientific literature on disabilities associated with mental disorders, insufficient attention has been paid to issues of gender in the context of mental disorder and disability. This paper draws on four data sets-the 199…
Mental Health, Disabilities, and Women
Ongoing development and reform of health care systems worldwide are directing the attention of policymakers to the significance of mental disorders and ensuing disabilities. While this awareness has encouraged empirical work and scientific literature on disabilities associated with mental disorders, insufficient attention has been paid to issues of gender in the context of mental disorder and disability. This paper draws on four data sets-the 199…
National Institute of Mental Health
Acting Director; Division of Services and Intervention Research; National Institute of Mental Health; Rockville, Maryland (Norquist) Chief; Services Research and Clinical; Epidemiology Branch; National Institute of Mental Health (Magruder)
Spillover Effects of Benefit Expansions and Carve-Outs on Psychotropic Medication Use and Costs
This paper extends the previous literature examining the impacts of managed behavioral health care carve-outs and mental health parity mandates on mental health and substance abuse (MH/SA) specialty treatment use and costs by considering the effects on psychotropic prescription medication costs. We use multivariate panel data methods to remove underlying secular growth trends, driven by increased demand for improved MH/SA treatment related to pha…
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established. The authors' primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder.…
A Window of Opportunity
The advisory meeting suggested that local policy makers, academics, and community members, together with federal agents, are working to implement behavioral health policy innovation
Feasibility of an Open Dialogue-Inspired Approach for Young Adults with Psychosis in a Public Hospital System
Medicine (6 obras) · Psychology (5 obras) · Mental health (4 obras) · Psychiatry (4 obras) · Health care (3 obras) · Nursing (3 obras) · Political science (3 obras) · Context (archaeology (2 obras) · Healthcare Policy and Management (2 obras) · Mental Health Treatment and Access (2 obras)